Tabrecta
Merck’s targeted lung cancer drug tepotinib wins early access in UK
Phil Taylor
Early Access to Medicines Scheme, Merck KGaA, MHRA, NSCLC, Tabrecta, Tepmetko, UK
0 Comment
X
Merck’s targeted lung cancer drug tepotinib wins early access in UK
https://pharmaphorum.com/news/mercks-targeted-lung-cancer-drug-tepotinib-wins-early-access-in-uk/
FDA starts quick review of Merck’s MET-targeting lung cancer drug
Phil Taylor
Merck KGaA, Non-small cell lung cancer, Novartis, novel targeted cancer treatments, Oncology, Tabrecta
0 Comment
X
FDA starts quick review of Merck’s MET-targeting lung cancer drug
https://pharmaphorum.com/news/fda-starts-quick-review-of-mercks-met-targeting-lung-cancer-drug/